Manhattan Scientifics, Inc. (MHTX)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -703 Thousand USD | -3.53% |
| 2022 | -679 Thousand USD | 1.16% |
| 2021 | -687 Thousand USD | -1.78% |
| 2020 | -675 Thousand USD | 34.15% |
| 2019 | -1.02 Million USD | 29.21% |
| 2018 | -1.44 Million USD | 36.44% |
| 2017 | -2.27 Million USD | 64.31% |
| 2016 | -6.38 Million USD | -2.11% |
| 2015 | -6.25 Million USD | -79.88% |
| 2014 | -3.47 Million USD | -92.2% |
| 2013 | -1.8 Million USD | -9.58% |
| 2012 | -1.65 Million USD | 23.96% |
| 2011 | -2.17 Million USD | -31100.0% |
| 2010 | 7000.00 USD | 101.76% |
| 2009 | -397 Thousand USD | 81.53% |
| 2008 | -2.15 Million USD | 37.55% |
| 2007 | -3.44 Million USD | -77.66% |
| 2006 | -1.93 Million USD | -19.78% |
| 2005 | -1.61 Million USD | 24.0% |
| 2004 | -2.12 Million USD | 23.11% |
| 2003 | -2.76 Million USD | 24.84% |
| 2002 | -3.68 Million USD | 42.72% |
| 2001 | -6.43 Million USD | -35.18% |
| 2000 | -4.75 Million USD | 50.11% |
| 1999 | -9.53 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -160 Thousand USD | 16.67% |
| 2024 Q1 | -192 Thousand USD | -27.15% |
| 2023 Q4 | -151 Thousand USD | 16.11% |
| 2023 Q1 | -186 Thousand USD | -6.9% |
| 2023 Q3 | -180 Thousand USD | 3.23% |
| 2023 Q2 | -186 Thousand USD | 0.0% |
| 2023 FY | -703 Thousand USD | -3.53% |
| 2022 Q4 | -174 Thousand USD | -3.57% |
| 2022 Q1 | -183 Thousand USD | -1207.14% |
| 2022 FY | -679 Thousand USD | 1.16% |
| 2022 Q2 | -154 Thousand USD | 15.85% |
| 2022 Q3 | -168 Thousand USD | -9.09% |
| 2021 Q1 | -184 Thousand USD | -4.55% |
| 2021 Q3 | -178 Thousand USD | -10.56% |
| 2021 Q2 | -161 Thousand USD | 12.5% |
| 2021 FY | -687 Thousand USD | -1.78% |
| 2021 Q4 | -14 Thousand USD | 92.13% |
| 2020 Q2 | -128 Thousand USD | 25.58% |
| 2020 Q1 | -172 Thousand USD | -17.81% |
| 2020 Q4 | -176 Thousand USD | 11.56% |
| 2020 FY | -675 Thousand USD | 34.15% |
| 2020 Q3 | -199 Thousand USD | -55.47% |
| 2019 FY | -1.02 Million USD | 29.21% |
| 2019 Q4 | -146 Thousand USD | 13.1% |
| 2019 Q3 | -168 Thousand USD | 65.71% |
| 2019 Q2 | -490 Thousand USD | -121.72% |
| 2019 Q1 | -221 Thousand USD | -140.77% |
| 2018 Q4 | 542 Thousand USD | 268.32% |
| 2018 FY | -1.44 Million USD | 36.44% |
| 2018 Q3 | -322 Thousand USD | 19.1% |
| 2018 Q2 | -398 Thousand USD | 7.23% |
| 2018 Q1 | -429 Thousand USD | 46.71% |
| 2017 Q4 | -805 Thousand USD | -225.91% |
| 2017 FY | -2.27 Million USD | 64.31% |
| 2017 Q3 | -247 Thousand USD | -174.4% |
| 2017 Q2 | 332 Thousand USD | 121.31% |
| 2017 Q1 | -1.55 Million USD | -13.64% |
| 2016 Q4 | -1.37 Million USD | -16.19% |
| 2016 Q1 | -1.77 Million USD | -37.28% |
| 2016 FY | -6.38 Million USD | -2.11% |
| 2016 Q2 | -2.06 Million USD | -16.06% |
| 2016 Q3 | -1.18 Million USD | 42.72% |
| 2015 FY | -6.25 Million USD | -79.88% |
| 2015 Q4 | -1.29 Million USD | 27.2% |
| 2015 Q3 | -1.77 Million USD | 5.63% |
| 2015 Q2 | -1.88 Million USD | -44.77% |
| 2015 Q1 | -1.3 Million USD | -75.44% |
| 2014 FY | -3.47 Million USD | -92.2% |
| 2014 Q4 | -741 Thousand USD | -8.33% |
| 2014 Q3 | -684 Thousand USD | 29.77% |
| 2014 Q1 | -1.07 Million USD | -171.16% |
| 2014 Q2 | -974 Thousand USD | 9.48% |
| 2013 Q4 | 1.51 Million USD | 152.85% |
| 2013 Q3 | -2.86 Million USD | -435.77% |
| 2013 Q2 | -534 Thousand USD | -812.0% |
| 2013 Q1 | 75 Thousand USD | 115.96% |
| 2013 FY | -1.8 Million USD | -9.58% |
| 2012 Q4 | -470 Thousand USD | -36.23% |
| 2012 Q2 | -404 Thousand USD | 6.26% |
| 2012 Q1 | -431 Thousand USD | -9.95% |
| 2012 FY | -1.65 Million USD | 23.96% |
| 2012 Q3 | -345 Thousand USD | 14.6% |
| 2011 FY | -2.17 Million USD | -31100.0% |
| 2011 Q4 | -392 Thousand USD | 62.77% |
| 2011 Q2 | -437 Thousand USD | -51.74% |
| 2011 Q3 | -1.05 Million USD | -140.96% |
| 2011 Q1 | -288 Thousand USD | -137.21% |
| 2010 FY | 7000.00 USD | 101.76% |
| 2010 Q4 | 774 Thousand USD | 338.15% |
| 2010 Q2 | -301 Thousand USD | -68.16% |
| 2010 Q3 | -325 Thousand USD | -7.97% |
| 2010 Q1 | -179 Thousand USD | 76.57% |
| 2009 Q2 | -197 Thousand USD | 38.63% |
| 2009 Q1 | -321 Thousand USD | -18.01% |
| 2009 FY | -397 Thousand USD | 81.53% |
| 2009 Q3 | -290 Thousand USD | -47.21% |
| 2009 Q4 | -764 Thousand USD | -163.45% |
| 2008 Q1 | -1.29 Million USD | 20.41% |
| 2008 Q3 | -290 Thousand USD | 2.36% |
| 2008 FY | -2.15 Million USD | 37.55% |
| 2008 Q4 | -272 Thousand USD | 6.21% |
| 2008 Q2 | -297 Thousand USD | 76.99% |
| 2007 Q3 | -394 Thousand USD | 64.38% |
| 2007 FY | -3.44 Million USD | -77.66% |
| 2007 Q4 | -1.62 Million USD | -311.68% |
| 2007 Q2 | -1.1 Million USD | -244.55% |
| 2007 Q1 | -321 Thousand USD | -64.62% |
| 2006 Q3 | -310 Thousand USD | 70.25% |
| 2006 Q4 | -195 Thousand USD | 37.1% |
| 2006 Q2 | -1.04 Million USD | -165.82% |
| 2006 FY | -1.93 Million USD | -19.78% |
| 2006 Q1 | -392 Thousand USD | -22.88% |
| 2005 FY | -1.61 Million USD | 24.0% |
| 2005 Q1 | -510 Thousand USD | -3.24% |
| 2005 Q2 | -441 Thousand USD | 13.53% |
| 2005 Q3 | -348 Thousand USD | 21.09% |
| 2005 Q4 | -319 Thousand USD | 8.33% |
| 2004 Q2 | -660 Thousand USD | -8.37% |
| 2004 Q4 | -494 Thousand USD | -34.97% |
| 2004 Q1 | -609 Thousand USD | 14.83% |
| 2004 FY | -2.12 Million USD | 23.11% |
| 2004 Q3 | -366 Thousand USD | 44.55% |
| 2003 Q1 | -612 Thousand USD | 48.0% |
| 2003 FY | -2.76 Million USD | 24.84% |
| 2003 Q4 | -715 Thousand USD | -77.42% |
| 2003 Q3 | -403 Thousand USD | 61.21% |
| 2003 Q2 | -1.03 Million USD | -69.77% |
| 2002 Q4 | -1.17 Million USD | -142.18% |
| 2002 FY | -3.68 Million USD | 42.72% |
| 2002 Q2 | -615 Thousand USD | 56.26% |
| 2002 Q1 | -1.4 Million USD | -51.18% |
| 2002 Q3 | -486 Thousand USD | 20.98% |
| 2001 Q1 | -2.03 Million USD | -40.96% |
| 2001 FY | -6.43 Million USD | -35.18% |
| 2001 Q4 | -930 Thousand USD | 15.68% |
| 2001 Q3 | -1.1 Million USD | 53.36% |
| 2001 Q2 | -2.36 Million USD | -16.27% |
| 2000 Q3 | -1.26 Million USD | -20.0% |
| 2000 Q4 | -1.44 Million USD | -13.98% |
| 2000 Q1 | -994 Thousand USD | 0.0% |
| 2000 FY | -4.75 Million USD | 50.11% |
| 2000 Q2 | -1.05 Million USD | -6.14% |
| 1999 FY | -9.53 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| CVR Medical Corp. | - USD | Infinity% |
| BioElectronics Corporation | -274.29 Thousand USD | -156.298% |
| IR-Med Inc. | -4.91 Million USD | 85.685% |
| Polarean Imaging plc | -12.55 Million USD | 94.401% |
| Medical Supply International USA, Inc. | 438.18 Thousand USD | 260.436% |
| Avitar, Inc. | 2.73 Million USD | 125.724% |
| AVITA Medical, Inc. | -40.4 Million USD | 98.26% |
| Össur hf. | 87.46 Million USD | 100.804% |
| Zecotek Photonics Inc. | -3.65 Million USD | 80.775% |
| QHSLab, Inc. | -240.15 Thousand USD | -192.724% |
| Wellstar International, Inc. | -1.79 Million USD | 60.829% |
| Össur hf. | 87.46 Million USD | 100.804% |
| Bionovate Technologies Corp | - USD | Infinity% |
| EKF Diagnostics Holdings plc | 2.08 Million USD | 133.782% |
| Escalon Medical Corp. | -104.47 Thousand USD | -572.882% |
| Aurora Spine Corporation | -446.19 Thousand USD | -57.554% |
| BrainsWay Ltd. | -4.92 Million USD | 85.732% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| NewCardio, Inc. | -9.45 Million USD | 92.568% |
| Hamilton Thorne Ltd. | 277.99 Thousand USD | 352.88% |
| Vivos Inc. | -2.79 Million USD | 74.831% |
| MicroPort Scientific Corporation | -516.16 Million USD | 99.864% |
| Kelyniam Global, Inc. | -239.16 Thousand USD | -193.938% |
| REMSleep Holdings, Inc. | -1.77 Million USD | 60.319% |
| CYduct Diagnostics, Inc. | -378.9 Thousand USD | -85.534% |
| Nanomix Corporation | -8.43 Million USD | 91.668% |
| Theraclion SA | -3.48 Million USD | 79.804% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| Wellness Center USA, Inc. | -707.02 Thousand USD | 0.57% |
| Positron Corporation | -1.36 Million USD | 48.337% |
| Rafina Innovations Inc. | - USD | Infinity% |
| Electromedical Technologies, Inc. | -2.06 Million USD | 65.955% |
| Lombard Medical, Inc. | -29.33 Million USD | 97.604% |
| ALR Technologies Inc. | -2.94 Million USD | 76.14% |
| Stratec SE | 25.26 Million USD | 102.782% |
| Vycor Medical, Inc. | 40.19 Thousand USD | 1849.148% |
| Heart Tronics, Inc. | 14.46 Million USD | 104.862% |
| Nu-Med Plus, Inc. | -120.52 Thousand USD | -483.277% |
| Perimeter Medical Imaging AI, Inc. | -20.72 Million USD | 96.609% |
| SANUWAVE Health, Inc. | -540 Thousand USD | -30.185% |
| VMS Rehab Systems, Inc. | -68.66 USD | -1023785.814% |
| Guided Therapeutics, Inc. | -3.45 Million USD | 79.664% |
| Ingen Technologies, Inc. | -1.61 Million USD | 56.434% |
| Odyssey Group International, Inc. | 14.26 Million USD | 104.93% |
| United American Healthcare Corporation | -67 Thousand USD | -949.254% |
| ECGI Holdings, Inc. | -407.48 Thousand USD | -72.524% |
| Capital Group Holdings, Inc. | -634.68 Thousand USD | -10.763% |
| ADM Tronics Unlimited, Inc. | -601.52 Thousand USD | -16.87% |
| Urologix, Inc. | -6.93 Million USD | 89.856% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.26 Million USD | 44.354% |
| Nexeon MedSystems Inc. | -6.26 Million USD | 88.779% |
| SS Innovations International, Inc. | -20.66 Million USD | 96.599% |
| Qualis Innovations, Inc. | -230.24 Thousand USD | -205.332% |
| Smith & Nephew plc | 425 Million USD | 100.165% |
| NIOX Group Plc | 4.6 Million USD | 115.283% |
| Fuse Medical, Inc. | 383.82 Thousand USD | 283.159% |
| Broncus Holding Corporation | -33.22 Million USD | 97.884% |
| Brain Scientific Inc. | -9.6 Million USD | 92.683% |
| Pressure BioSciences, Inc. | -9.5 Million USD | 92.603% |
| Health Logic Interactive Inc. | -60.69 Thousand USD | -1058.174% |